Related references
Note: Only part of the references are listed.Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm
Coen J. Lap et al.
CASE REPORTS IN HEMATOLOGY (2021)
IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment
Victor Baeza et al.
SCIENTIFIC REPORTS (2021)
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Juliana Schwaab et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes. Version 3.2021
Aaron T. Gerds et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice
Alvaro Cuesta-Dominguez et al.
JOURNAL OF PATHOLOGY (2015)
JAK2V617F/TET2 mutations: does the order matter?
Elodie Pronier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)